CLINICAL TRIAL SUMMARY

MDACC Study No:2006-0521 (clinicaltrials.gov NCT No: NCT00516243)
Title:Phase 1b Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Women with a History of Hormone Receptor-Negative Breast Cancer
Principal Investigator:Therese B. Bevers
Treatment Agent:Polyphenon E
Study Status:Terminated
Study Description:The goal of this clinical research study is to find the highest tolerable dose
of the Polyphenon E (Poly E) that can be given to patients who have had hormone
receptor-negative breast cancer. Another goal is to test the safety of Poly E
at different dose levels.

Hide details for General InformationGeneral Information

Disease Group:Breast
Phase of Study:Phase I
Treatment Agents:Polyphenon E
Treatment Location:Independent Multicenter Arrangements
Estimated Length of Stay in Houston:Not applicable
Supported By:N/A
Return Visit:8 visits during study
Home Care:Not applicable


Hide details for Study Contact InformationStudy Contact Information

Physician Name:Therese B. Bevers
Dept:Clinical Cancer Prevention
For Clinical Trial Enrollment:713-745-8048
For General Questions about Clinical Trials:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)


Show details for Study Objectives / OutcomesStudy Objectives / Outcomes
Show details for Study Status InformationStudy Status Information
Show details for Enrollment EligibilityEnrollment Eligibility
Show details for Resources and LinksResources and Links
Show details for ResultsResults